Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04226196
Other study ID # ConTRol
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 27, 2020
Est. completion date April 2021

Study information

Verified date April 2020
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study should investigate the influence of a capsular tension ring on postoperative rotational stability of a plate haptic hydrophilic acrylic intraocular lens. All patients will be operated on both eyes in one occasion. Both eyes receive a Zeiss 409MP plate haptic intraocular lens, while only on eye receives an additional capsular tension ring. Follow up visits take place 1 hour, 1 week, 1 month and 4 to 7 months after surgery. At the follow up visits, the actual IOL axis will be determined by retroillumination photography. IOL centration and tilt will be determined by anterior segment SS-OCT Casia II. IOLs will be implanted in 4 different axis 0 +/- 10 degrees, 45 +/- 10 degrees, 90 +/- 10 degrees, 135 +/- 10 degrees. IOL rotation, decentration and tilt then will be compared intraindividually.


Recruitment information / eligibility

Status Recruiting
Enrollment 65
Est. completion date April 2021
Est. primary completion date April 2021
Accepts healthy volunteers No
Gender All
Age group 45 Years to 95 Years
Eligibility Inclusion Criteria:

- Bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation

- Need for spherical IOL correction between +0.00 and +32.00 D

- Pupil dilation of = 7.0 mm

- Age 45 to 95

Exclusion Criteria:

- Corneal abnormality (Corneal scaring)

- Preceding ocular surgery or trauma

- Uncontrolled glaucoma

- Proliferative diabetic retinopathy

- Iris neovascularization

- History of uveitis/iritis

- Microphthalmus

- Recurrent intraocular inflammation of unknown etiology Uncontrolled systemic or ocular disease

- Pregnancy

- Lactation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Implantation of an intraocular lens
Implantation of an intraocular lens Zeiss 409 MP into the capsular bag using an injector, after removing of the human crystalline lens.

Locations

Country Name City State
Austria Medical University of Vienna Allgemeines Krankenhaus Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of axial intraocular lens position Change in axis position of an intraocular lens Zeiss 409 MP from end of surgery (baseline axis) to 1 hour, 1 week, 1 month and 4-7 months (end of study visit). The change in axis position will be evaluated with respect to the baseline measurement at the end of surgery. Differences in axis position will be described as rotation in degrees (0 to 360°) 7 months
Secondary Decentration Decentration of the intraocular lens will be measured with the Casia 2 OCT. Decentration will be described as "Decentration in millimeter" 7 months
Secondary Tilt Tilt of the intraocular lens will be measured with the Casia 2 OCT. Tilt will be described as "Tilt in degrees at a certain axis" 7 months
Secondary Anterior chamber depth The anterior chamber depth (Axial position of the IOL) of the intraocular lens will be measured with the Casia 2 OCT after 1 month. The anterior chamber depth will be measured in millimeter 7 months
Secondary Best corrected visual acuity (BCVA) BCVA will be measured at 1 week, 1 month and 4 to 7 months. The BCVA will be described as the minimum angle of resolution (logMar) 7 months
See also
  Status Clinical Trial Phase
Completed NCT05530473 - Combined Capsular Tension Ring and IOL Implantation for Management of Cataracts N/A
Recruiting NCT06294405 - Intraocular Lens Implant Registry Study